Literature DB >> 28281307

Integrated expression analysis identifies transcription networks in mouse and human gastric neoplasia.

Zheng Chen1,2,3, Mohammed Soutto1,2,3, Bushra Rahman2,3, Muhammad W Fazili2,3, DunFa Peng2,3, Maria Blanca Piazuelo4,5, Heidi Chen6, M Kay Washington7, Yu Shyr6, Wael El-Rifai1,2,3.   

Abstract

Gastric cancer (GC) is a leading cause of cancer-related deaths worldwide. The Tff1 knockout (KO) mouse model develops gastric lesions that include low-grade dysplasia (LGD), high-grade dysplasia (HGD), and adenocarcinomas. In this study, we used Affymetrix microarrays gene expression platforms for analysis of molecular signatures in the mouse stomach [Tff1-KO (LGD) and Tff1 wild-type (normal)] and human gastric cancer tissues and their adjacent normal tissue samples. Combined integrated bioinformatics analysis of mouse and human datasets indicated that 172 genes were consistently deregulated in both human gastric cancer samples and Tff1-KO LGD lesions (P < .05). Using Ingenuity pathway analysis, these genes mapped to important transcription networks that include MYC, STAT3, β-catenin, RELA, NFATC2, HIF1A, and ETS1 in both human and mouse. Further analysis demonstrated activation of FOXM1 and inhibition of TP53 transcription networks in human gastric cancers but not in Tff1-KO LGD lesions. Using real-time RT-PCR, we validated the deregulated expression of several genes (VCAM1, BGN, CLDN2, COL1A1, COL1A2, COL3A1, EpCAM, IFITM1, MMP9, MMP12, MMP14, PDGFRB, PLAU, and TIMP1) that map to altered transcription networks in both mouse and human gastric neoplasia. Our study demonstrates significant similarities in deregulated transcription networks in human gastric cancer and gastric tumorigenesis in the Tff1-KO mouse model. The data also suggest that activation of MYC, STAT3, RELA, and β-catenin transcription networks could be an early molecular step in gastric carcinogenesis.
© 2017 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2017        PMID: 28281307      PMCID: PMC5524517          DOI: 10.1002/gcc.22456

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  69 in total

1.  Helicobacter pylori targets cancer-associated apical-junctional constituents in gastroids and gastric epithelial cells.

Authors:  Lydia E Wroblewski; M Blanca Piazuelo; Rupesh Chaturvedi; Michael Schumacher; Eitaro Aihara; Rui Feng; Jennifer M Noto; Alberto Delgado; Dawn A Israel; Yana Zavros; Marshall H Montrose; Noah Shroyer; Pelayo Correa; Keith T Wilson; Richard M Peek
Journal:  Gut       Date:  2014-08-14       Impact factor: 23.059

2.  Overexpression of CEBPbeta correlates with decreased TFF1 in gastric cancer.

Authors:  N V Sankpal; C A Moskaluk; G M Hampton; S M Powell
Journal:  Oncogene       Date:  2006-01-26       Impact factor: 9.867

Review 3.  Apoptotic signaling by c-MYC.

Authors:  B Hoffman; D A Liebermann
Journal:  Oncogene       Date:  2008-10-27       Impact factor: 9.867

4.  The Forkhead Box m1 transcription factor stimulates the proliferation of tumor cells during development of lung cancer.

Authors:  Il-Man Kim; Timothy Ackerson; Sneha Ramakrishna; Maria Tretiakova; I-Ching Wang; Tanya V Kalin; Michael L Major; Galina A Gusarova; Helena M Yoder; Robert H Costa; Vladimir V Kalinichenko
Journal:  Cancer Res       Date:  2006-02-15       Impact factor: 12.701

5.  Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012.

Authors:  Jacques Ferlay; Isabelle Soerjomataram; Rajesh Dikshit; Sultan Eser; Colin Mathers; Marise Rebelo; Donald Maxwell Parkin; David Forman; Freddie Bray
Journal:  Int J Cancer       Date:  2014-10-09       Impact factor: 7.396

6.  Claudin-2 expression increases tumorigenicity of colon cancer cells: role of epidermal growth factor receptor activation.

Authors:  P Dhawan; R Ahmad; R Chaturvedi; J J Smith; R Midha; M K Mittal; M Krishnan; X Chen; S Eschrich; T J Yeatman; R C Harris; M K Washington; K T Wilson; R D Beauchamp; A B Singh
Journal:  Oncogene       Date:  2011-03-07       Impact factor: 9.867

7.  Loss of TFF1 promotes Helicobacter pylori-induced β-catenin activation and gastric tumorigenesis.

Authors:  Mohammed Soutto; Judith Romero-Gallo; Uma Krishna; M Blanca Piazuelo; M Kay Washington; Abbes Belkhiri; Richard M Peek; Wael El-Rifai
Journal:  Oncotarget       Date:  2015-07-20

8.  By inhibiting Ras/Raf/ERK and MMP-9, knockdown of EpCAM inhibits breast cancer cell growth and metastasis.

Authors:  Jiujiao Gao; Xue Liu; Fan Yang; Tingjiao Liu; Qiu Yan; Xuesong Yang
Journal:  Oncotarget       Date:  2015-09-29

9.  Statins affect ETS1-overexpressing triple-negative breast cancer cells by restoring DUSP4 deficiency.

Authors:  Hae Hyun Jung; Soo-Hyeon Lee; Ji-Yeon Kim; Jin Seok Ahn; Yeon Hee Park; Young-Hyuck Im
Journal:  Sci Rep       Date:  2016-09-08       Impact factor: 4.379

10.  Inhibition of the JAK2/STAT3 pathway reduces gastric cancer growth in vitro and in vivo.

Authors:  Louise M Judd; Treve R Menheniott; Hui Ling; Cameron B Jackson; Meegan Howlett; Anastasia Kalantzis; Waldemar Priebe; Andrew S Giraud
Journal:  PLoS One       Date:  2014-05-07       Impact factor: 3.240

View more
  7 in total

1.  Bioinformatics analysis of potential Key lncRNA-miRNA-mRNA molecules as prognostic markers and important ceRNA axes in gastric cancer.

Authors:  Siqi Tang; Keyong Liao; Yongpeng Shi; Tingting Tang; Beibei Cui; Zunnan Huang
Journal:  Am J Cancer Res       Date:  2022-05-15       Impact factor: 5.942

2.  Identification of Potential Key Genes Associated With the Pathogenesis and Prognosis of Gastric Cancer Based on Integrated Bioinformatics Analysis.

Authors:  Xinkui Liu; Jiarui Wu; Dan Zhang; Zhitong Bing; Jinhui Tian; Mengwei Ni; Xiaomeng Zhang; Ziqi Meng; Shuyu Liu
Journal:  Front Genet       Date:  2018-07-17       Impact factor: 4.599

3.  P4HA3 is Epigenetically Activated by Slug in Gastric Cancer and its Deregulation is Associated With Enhanced Metastasis and Poor Survival.

Authors:  Hu Song; Lingling Liu; Zhaoquan Song; Yongqiang Ren; Chao Li; Jiege Huo
Journal:  Technol Cancer Res Treat       Date:  2018-01-01

4.  Activation of STAT3 signaling is mediated by TFF1 silencing in gastric neoplasia.

Authors:  Mohammed Soutto; Zheng Chen; Ajaz A Bhat; Lihong Wang; Shoumin Zhu; Ahmed Gomaa; Andreia Bates; Nadeem S Bhat; Dunfa Peng; Abbes Belkhiri; M Blanca Piazuelo; M Kay Washington; Xi Chen Steven; Richard Peek; Wael El-Rifai
Journal:  Nat Commun       Date:  2019-07-10       Impact factor: 14.919

5.  Combination of IFITM1 knockdown and radiotherapy inhibits the growth of oral cancer.

Authors:  Jie Yang; Lei Li; Yan Xi; Ruimei Sun; Hu Wang; Yanxin Ren; Liufang Zhao; Xiaoli Wang; Xiaojiang Li
Journal:  Cancer Sci       Date:  2018-09-21       Impact factor: 6.716

6.  Molecular Alterations in the Stomach of Tff1-Deficient Mice: Early Steps in Antral Carcinogenesis.

Authors:  Eva B Znalesniak; Franz Salm; Werner Hoffmann
Journal:  Int J Mol Sci       Date:  2020-01-18       Impact factor: 5.923

7.  Data mining-based study of collagen type III alpha 1 (COL3A1) prognostic value and immune exploration in pan-cancer.

Authors:  Hanyu Zhang; Cheng Ding; Yatong Li; Cheng Xing; Shunda Wang; Zhangping Yu; Lixin Chen; Pengyu Li; Menghua Dai
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.